Κλαύδιος Γαληνός
Δωρεάν εγγραφή Αποκτήσετε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr για έναν μήνα
Έλεγχος συγχορήγησης Ελέγξτε την αγωγή σας για αντενδείξεις και αλληλεπιδράσεις μεταξύ των φαρμάκων
Μητρότητα και φάρμακα Ενημερωθείτε για την ασφάλεια χορήγησης ενός φαρμάκου κατά τη διάρκεια της εγκυμοσύνης ή του θηλασμού
Συνδρομές Μάθετε περισσότερα για τα οφέλη και τις επιπλέον παροχές των συνδρομητικών προγραμμάτων
Ενδείξεις και αγωγές Βρείτε θεραπευτικές ενδείξεις και αγωγές για νόσους, συμπτώματα και ιατρικές πράξεις
Γνωρίζατε ότι... Μοιραζόμαστε μαζί σας γεγονότα της πορείας του Galinos.gr από το 2011 μέχρι σήμερα

DAKTARIN Cream (2016)

Αναφορές

Βιβλιογραφική αναφορά

Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή

Περιεχόμενα

Name of the medicinal product

Daktarin 2% Cream.

Qualitative and quantitative composition

Miconazole nitrate 2% w/w. Excipients: Benzoic acid, Butylated hydroxyanisole. For a full list of excipients, see Section 6.1.

Pharmaceutical form

Cream. White homogeneous cream.

Therapeutic indications

For the treatment of mycotic infections of the skin and nails and superinfections due to Gram-positive bacteria.

Posology and method of administration

Route of administration: Cutaneous use. Recommended dosage For all ages Fungal infections of the skin Apply some cream to the lesions two times daily. Rub the cream into the skin with your finger until ...

Contraindications

Hypersensitivity to the active substances(s), other imidazole derivatives or to any of the excipients listed in section 6.1.

Special warnings and precautions for use

Daktarin Cream must not come into contact with the mucosa of the eyes. Severe hypersensitivity reactions, including anaphylaxis and angioedema, have been reported during treatment with Daktarin Cream and ...

Interaction with other medicinal products and other forms of interaction

Miconazole administered systemically is known to inhibit CYP3A4/2C9. Due to the limited systemic availability after topical application, clinically relevant interactions are rare. However, in patients ...

Pregnancy and lactation

Pregnancy In animals miconazole nitrate has shown no teratogenic effects but is foetotoxic at high oral doses. Only small amounts of miconazole nitrate are absorbed following topical administration. However, ...

Effects on ability to drive and use machines

Not relevant.

Undesirable effects

Adverse drug reactions reported among 834 patients who received miconazole nitrate 2% cream (n=426) and/or placebo cream base (n=408) in 21 double-blind clinical trials are presented in Table 1 below. ...

Overdose

Symptoms Cutaneous use: Excessive use can result in skin irritation, which usually disappears after discontinuation of therapy. Treatment Daktarin cream is intended for cutaneous use, not for oral use. ...

Pharmacodynamic properties

Pharmacotherapeutic classification: Antifungals for dermatological/topical use; imidazole derivative ATC code: D01AC02 Miconazole nitrate is an imidazole antifungal agent and may act by interfering with ...

Pharmacokinetic properties

Absorption There is little absorption through skin or mucous membranes when miconazole nitrate is applied topically. Distribution Absorbed miconazole is bound to plasma proteins (88.2%) and red blood cells ...

Preclinical safety data

Preclinical data reveal no special hazard for humans based on conventional studies of local irritation, single and repeated dose toxicity, genotoxicity, and toxicity to reproduction.

List of excipients

PEG-6, PEG-32 and glycol stearate Oleoyl macroglycerides Liquid paraffin Benzoic acid (E210) Butylated hydroxyanisole (E320) Purified water

Incompatibilities

Not applicable.

Shelf life

Shelf life: 24 months.

Special precautions for storage

Do not store above 25°C.

Nature and contents of container

Aluminium tube inner lined with heat polymerised epoxy-phenol resin with a white polypropylene cap containing 15g, 30g or 70g of cream, or aluminium tube inner lined with heat polymerised epoxy-phenol ...

Special precautions for disposal and other handling

No special requirements. Any unused product or waste material should be disposed of in accordance with local requirements.

Marketing authorization holder

McNeil Products Limited, Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UG, United Kingdom

Marketing authorization number(s)

PL 15513/0307

Date of first authorization / renewal of the authorization

01/04/2009

Date of revision of the text

08 August 2016

Πηγαίο έγγραφο

Το πηγαίο έγγραφο για αυτήν την βιβλιογραφική αναφορά είναι διαθέσιμο προς μεταφόρτωση:

Μπορείτε να υποστηρίξετε τον Γαληνό στην αποστολή του να παρέχει δωρεάν έγκυρη πληροφόρηση για κάθε φάρμακο απενεργοποιώντας το Ad Blocker για αυτόν τον ιστότοπο.